What’s a total !@#$ show these stocks are been at a total loss for ages
Uross03
il y a 6 mois
Im in
In at 1.42
Wish me luck (if there’s any)!
Cl1f0
il y a 6 mois
VOLUME IS UP⬆️⬆️⬆️
Little spike and looking at the volume there will be another soon. No merger yet but I keep saying we only need to stay above $1 for another week and then we have a high percentage of merger talks thats when we see a rocket. But thats wont be the half of it any of these private companies are looking to merge. And let me tell you they are looking for a shell. Then this is a game changer. It does have to happen to be a game changer but QNCX has the best fit out of all the shells.
1. Xaira Therapeutics
Backing: Launched in April 2024 with $1 billion in committed funding from major firms like ARCH Venture Partners and Foresite Capital.
Why it fits: It is one of the only private biotechs to actually hit the $1 billion funding mark in a single launch. They focus on AI-driven drug discovery, a high-value sector that often attracts significant investor interest.
2. Kailera Therapeutics
Backing: Has raised approximately $1 billion in total private funding as of late 2025/early 2026, including a massive $600 million Series B.
Industry Focus: Obesity (GLP-1) and related metabolic diseases.
Status: While they recently launched an IPO roadshow, many companies in this sector keep a "dual-track" strategy, meaning they evaluate reverse mergers with shells like QNCX simultaneously with IPO plans.
3. Eikon Therapeutics
Backing: Valued at approximately $3.2 billion with significant private backing from investors like T. Rowe Price and Canada Pension Plan Investment Board.
Industry Focus: Advanced microscopy and drug discovery.
Recent Activity: They recently completed an IPO in early 2026, but were long considered a primary candidate for a major public market entry.
idk30008
il y a 6 mois
Can we pls see news today !!
Honestly what was the point of clearing debt and doing a 10-1 split, if this was gonna die and if we weren’t gonna stay above $1, hopefully there’s news today or tomorrow, or consider this dead
Analyst101
il y a 6 mois
Somethings happening behind closed doors
cianlewis
il y a 6 mois
RS completed
the halt is over, let's push
Cl1f0
il y a 6 mois
RS 1-for-10 if a merger is on the cards
Ive been doing a little digging and found some previous similar scenarios all available for you to look the Internet. Because Its blown my mind how $5.5m has been paid if they expect to go bankrupt.
Therefore i think there is something in the pipeline. Everything is strictly private and no info to be given.
So asking AI to find me similar scenarios
1. MDGL 2. IRON 3. TECX 4.LH 5. BKNG
The first 3 have similar failed drug trail and then were merged after RS as a shell and not failed company, they are all above $30.72 and MDGL is $527.
I believe we have potential to be sitting pretty here. Im not selling and if it stays above $1 then we look like were have a good start. Pretty sure it has to hold for an actual handshake but this could be one of them gems. Fingers crossed. And for all you holding im with you. NFA
Cette page peut contenir du contenu généré par la communauté dont Trading 212 n'est pas responsable. Effectue toujours tes propres recherches. Trading 212 ne propose qu'un service d'exécution et ne propose pas des conseils en investissement ou des services de gestion de portefeuille.
Se constituer de la richesse relève de l'habitude. Automatise le processus avec un Pie.
Investis dans des Pies prêts à l'emploi, ou crée le tien à partir de milliers d'actions et d'ETFs
En savoir plus
En savoir plus
Regarde la vidéo
Tu peux même détenir les actions les plus chères comme Google, Amazon et Apple
Regarde la vidéo
Euronext Paris
NYSE, NASDAQ
Xetra, Gettex
Euronext Amsterdam
Bolsa de Madrid
Wiener Börse
London Stock Exchange
Euronext Lisbon
Euronext Paris
NYSE, NASDAQ
Xetra, Gettex
Euronext Amsterdam
Bolsa de Madrid
Wiener Börse
London Stock Exchange
Euronext Lisbon
Voir tous les instruments de trading
Assistance 24/7
Temps de réponse moyen de 29 secondes
Commence à t'enrichir dès maintenant
Rejoins plus de 5 millions d'utilisateurs
Obtenir l'application
Ouvrir un compte
Télécharge l'application mobile
Toutes les statistiques présentées sont mondiales. Le nombre de clients représente des comptes financés.
Excellent
Noté 4,6 / 5 d'après les 106 426 avis sur
Trustpilot
Noté 4,6 / 5 d'après les 106 426 avis sur
Trustpilot
Invité
Excellent
Using Trading 212 has been a very productive and satisfying experience for me. Because the platform is user-friendly, dependable, and simple to navigate, investing is made to be a straightforward and convenient process. I am especially grateful for the user-friendly interface, the useful investment tools, and the capability to track the performance of my portfolio in real time.
Invité
I have had a fantastic experience with…
have had a fantastic experience with Trading 212. The app is modern, intuitive and incredibly easy to use, making investing feel accessible and straightforward. I particularly appreciate the clear layout, real-time updates and the ability to manage my investments conveniently in one place. The overall experience is smooth, efficient and user-friendly. Whether you are new to investing or more experienced, Trading 212 is an excellent platform that I would happily recommend to others. A brilliant app that makes investing simple!
Invité
Easy to use and fantastic features
Easy to use and fantastic features
Invité
Easy to operate app for everyone!
Easy to operate app for everyone!
Invité
Good platform for all my investments in…
Good platform for all my investments in one place. I have ISA and recently transferred my SIPP. I have a general investment account link to 121 debit card.
Invité
Awesome service and app
Awesome service and app. Well done guys :)
Invité
Everything is just so easy to use
Everything is just so easy to use. You can see at a glance how everything is doing.
Invité
Just a great platform user friendly 0…
Just a great platform user friendly 0 commissions with the pie attachment whats not to like choosing 212 compared to other platforms is literally a no brainer
Invité
Great app easy to move money in/out…
Great app easy to move money in and out. Good to see how much interest you are making.
Invité
Easy to use and intuitive
Easy to use and great dashboard to see what’s going on. Moved my stocks and shares ISA from Barclays and not looked back.
Invité
Easy to use app
Easy to use app, simple processes, good rate of return and regular updates on interest earned.
Invité
Quick and easy
I found that it was quick and easy to open an account; transfer funds in and out, best of all, to sit back and watch the monies increase.
I would recommend Trading 212
Invité
App is easy to use
The savings product i have has a good rate of return and I get daily updates. App is really easy to use
Invité
212 has been a good discovery 6 years ago
212 has been a good discovery. Excellent platform for investment, secure and user friendly. Very good interest rate and good ISA
Invité
Love it
Love it. Simple for a complete beginner to navigate. Perfect!
Invité
The best app around
The best app around, so easy to use and navigate… makes investing easy.
Invité
Easy access to transfer money.
Easy access to transfer money.
Daily updates regarding interest.
Invité
Great platform
Great platform, easy to navigate and buy/sell. Good statements are available.
Invité
Trading 212 is very transparent
Trading 212 is very transparent, open and clear with their activities. No outrageous deductions or charges. I recommend it for everyone interested in investment
Invité
Good and efficient
Good and easy to use with lots of products and investment options
Afficher certains avis positifs de clients
Nos récompenses
Foire aux questions
Quel est le cours de l'action IRulya Therapeutics?
Le prix actuel de IRulya Therapeutics est 33,08 $.
Quel est le plus haut sur 52 semaines de IRulya Therapeutics?
Le plus haut sur 52 semaines pour IRulya Therapeutics est 908 $.
Quel est le plus bas sur 52 semaines de IRulya Therapeutics?
Le plus bas sur 52 semaines pour IRulya Therapeutics est 15,1 $.
Quelle est la performance hebdomadaire de IRulya Therapeutics?
Au cours de la semaine dernière, le prix de IRulya Therapeutics a changé de 3,28 %.
Quelle est la performance mensuelle de IRulya Therapeutics?
Au cours du mois dernier, le prix de IRulya Therapeutics a changé de 5,52 %.
Quelle est la performance sur 3 mois de IRulya Therapeutics?
Au cours des trois derniers mois, le prix de IRulya Therapeutics a changé de 78,43 %.
Quelle est la performance sur 6 mois de IRulya Therapeutics?
Au cours des six derniers mois, le prix de IRulya Therapeutics a changé de 20,73 %.
Quelle est la performance annuelle de IRulya Therapeutics?
Au cours de l'année écoulée, le prix de IRulya Therapeutics a changé de -90,91 %.